Zobrazeno 1 - 10
of 19
pro vyhledávání: '"L. Santoyo-Fexas"'
Autor:
C. M. Gamboa-Alonso, A. Moreno-Salinas, L. Santoyo-Fexas, G. Figueroa-Parra, D. Á. Galarza-Delgado, Ana Laura De Leon-Ibarra, Jorge A. Esquivel-Valerio
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Patients with rheumatic diseases (RD) have a higher risk of morbidity and mortality from vaccine-preventable infections attributed to disease activity, comorbidities, immunosuppressive therapy, and other factors. Vaccines are one of the safest and mo
Publikováno v:
Kidney International Reports. 7:S367-S368
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rodolfo Uriarte-Botello, D. Á. Galarza-Delgado, Griselda Serna-Peña, César V. Elizondo-Solis, Mario Alberto Garza-Elizondo, Miguel Ángel Villarreal-Alarcón, R. Pineda-Sic, L. Santoyo-Fexas, Ana Sofía Leal-Bramasco, Octavio Ilizaliturri-Guerra
Publikováno v:
Rheumatology international. 40(10)
Systemic lupus erythematosus (SLE) is an autoimmune disease, characterized by multi-organ symptomatology. 16% of the patients with autoimmune thrombocytopenia have SLE and are associated with high mortality. Intravenous methylprednisolone or high-dos
Autor:
I. D. J. Hernandez-Galarza, L. Santoyo-Fexas, A. Moreno-Salinas, A. S. Leal Bramasco, D. Á. Galarza-Delgado, M. E. Corral Trujillo, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 79:556-557
Background:Cognition is the ability to learn, process and remember information to be used later.(1) Cognitive impairment reflects a decrease in one or more cognitive domains: memory, language, reasoning, among others.(2) It has been reported in rheum
Autor:
Griselda Serna-Peña, Gisela García-Arellano, Luis Adrián Rendón-Pérez, Juan Manuel Muñoz-Ayala, Berenice Soto-Monciváis, L. Santoyo-Fexas, Mayra Alexandra Rendón-Medina, D. Á. Galarza-Delgado, Juan Pablo Carrizales-Luna
Publikováno v:
Poster Presentations.
Background: RA patients have high latent tuberculosis(LTBI)prevalence(20-37%)1. In Mexico,ranges from 21.7% to 31.3% using tuberculin skin test (TST)2. The methods to detect LTBI are TST and IGRAs. QuantiFERON Gold-Plus (QTF-Plus)uses an antigen tube
Autor:
M. Eguia Bernal, Griselda Serna-Peña, D. Á. Galarza-Delgado, David Vega-Morales, R. Pineda-Sic, M. M. Castañeda-Martínez, L. Santoyo-Fexas, D. E. Flores Alvarado, L. Pérez Barbosa, Janett Riega-Torres, Miguel Ángel Villarreal-Alarcón, I. D. J. Hernandez-Galarza
Publikováno v:
Annals of the Rheumatic Diseases. 79:899.2-899
Background:Rheumatoid Factor (RF) is used for the classification of Rheumatoid arthritis (RA) in patients whose main complaint is hand arthritis but is well known that other conditions have positive RF. Differences in analytical performance between a
Autor:
D. Á. Galarza-Delgado, R. A. Uriarte Botello, L. Santoyo-Fexas, C. V. Solis, J. A. Icazbalceta-De la Peña, J. A. Esquivel Valerio, Iris Jazmin Colunga-Pedraza, R. E. Díaz-García
Publikováno v:
Annals of the Rheumatic Diseases. 79:615.1-615
Background:Rheumatoid Arthritis (RA) has been associated with depression by up to 46% (1)Within the universe of manifestations of depression is learned helplessness (LH)LH is defined as an inadequate perception of the disease, generating feelings of
Autor:
M. Eguia Bernal, R. A. Uriarte Botello, D. Á. Galarza-Delgado, B. R. Vázquez Fuentes, L. Santoyo-Fexas, C. M. Skinner Taylor, I. D. J. Hernandez-Galarza, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 79:1936-1936
Background:Medication error can be defined as a failure in the treatment process that leads to or has the potential to lead to harm to the patient, this fault can happen in two different phases: prescribing and prescription.Prescribing is the process
Autor:
I. D. J. Hernandez-Galarza, D. Á. Galarza-Delgado, L. Santoyo-Fexas, C. M. Skinner Taylor, C. V. Solis, B. R. Vázquez Fuentes, R. A. Uriarte Botello, M. Eguia Bernal
Publikováno v:
Annals of the Rheumatic Diseases. 79:1935.1-1936
Background:Pharmacovigilance is the science and activities related to detection, evaluation, understanding and prevention of adverse effects of medications or any other health problem related to them. (1)Within the scope of the pharmacovigilance stud